Scinai Immunotherapeutics Ltd. American Depositary Shares
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCNI and other ETFs, options, and stocks.About SCNI
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza.
CEOAmir Reichman
CEOAmir Reichman
Employees31
Employees31
HeadquartersJerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded2003
Founded2003
Employees31
Employees31
SCNI Key Statistics
Market cap1.02M
Market cap1.02M
Price-Earnings ratio-0.10
Price-Earnings ratio-0.10
Dividend yield—
Dividend yield—
Average volume53.76K
Average volume53.76K
High today$1.26
High today$1.26
Low today$1.20
Low today$1.20
Open price$1.23
Open price$1.23
Volume18.10K
Volume18.10K
52 Week high$6.18
52 Week high$6.18
52 Week low$0.86
52 Week low$0.86
Stock Snapshot
With a market cap of 1.02M, Scinai Immunotherapeutics Ltd. American Depositary Shares(SCNI) trades at $1.21. The stock has a price-to-earnings ratio of -0.10.
On 2025-12-14, Scinai Immunotherapeutics Ltd. American Depositary Shares(SCNI) stock moved within a range of $1.20 to $1.26. With shares now at $1.21, the stock is trading +0.8% above its intraday low and -3.7% below the session's peak.
Trading activity shows a volume of 18.1K, compared to an average daily volume of 53.76K.
The stock's 52-week range extends from a low of $0.86 to a high of $6.18.
The stock's 52-week range extends from a low of $0.86 to a high of $6.18.